Inflation eases in Turkey although Trump tariffs pose economic risks
Turkey's annual inflation rate dropped to 38.1% in March, down from February's 39.1%, according to the Turkish Statistical Institute.
This was below analyst estimates of 38.9%, while also marking the 10th consecutive month of falling inflation. It was also the lowest number since December 2021.
Prices rose at a slower pace across a number of categories, such as footwear and clothing, which came in at 14.8% in March, down from 20.8% in the previous month.
Transport inflation dropped to 21.6% in March, down from 23.4% in February.
Household equipment and furnishings inflation slid marginally to 32.4% in March, down from 33.6% in the previous month.
Similarly, health inflation dropped to 42% in March, from 43% in February, while cafe, hotels and restaurant inflation came down from 45.9% in February to 43.4% in March. Recreation and culture price rises also eased.
However, non-alcoholic beverage and food inflation advanced slightly to 37.1% in March, up from 35.1% in February.
Month-on-month Turkish inflation rose 2.5% in March, up from 2.3% in February.
Although Turkey's inflation rate has been on a downward trajectory for the last 10 months, it is still considerably higher than most other countries. However, the Central Bank of the Republic of Turkey has already started slashing interest rates, having decreased its key rate by 250 basis points to 42.5% in early March.
The country still has considerable upside risks to inflation, including the recently announced US 10% baseline tariff. With Turkish inflation already significantly high, the central bank will be carefully considering any upcoming decision which could push it higher.
Related
Prospects brighten as Turkey taken off money laundering 'grey list'
Turkey cuts interest rate to 42.5% after inflation hits two-year low
Previously, when dealing with soaring inflation, the central bank cut interest rates, an approach supported by President Recep Tayyip Erdoğan, which was completely at odds with strategies taken in other major economies.
However, when this pulled the lira down and pushed inflation up, the central bank changed tack and started hiking interest rates.
The European Bank for Reconstruction and Development (EBRD) estimated in its February Regional Economic Prospects report that Turkey's economy would grow by 3% this year. This echoed its forecast given in September last year.
The bank also expects Turkey's gross domestic product (GDP) to hit 3.5% next year.
However, the EBRD warned that geopolitical uncertainties and sticky inflation still continue to present downside risks to the Turkish economy. It also warned against rapid monetary policy loosening.
'For Türkiye, the report indicates that tighter monetary and fiscal policies have led to a significant reduction in inflation and improvements in the country's external position, with net exports rising and the current account deficit declining steadily," the EBRD said.
'However, the report warns against premature loosening of policy measures, with continued high inflation, geopolitical uncertainties and the impact of the real appreciation of the Turkish lira on export competitiveness all posing downside risks to the economy.'
The country's economic outlook is also vulnerable to global financing conditions, mainly because of its high short-term external financing needs.
Turkey's economic outlook is also clouded by political turmoil following the arrest of Istanbul mayor Ekrem Imamoglu, the opponent of President Tayyip Erdogan, last month.
The detention sparked mass protests and critics of Erdogan are now calling for a mass commercial boycott, encouraging citizens to forgo goods and services from firms perceived as close to the president.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Boston Globe
2 days ago
- Boston Globe
Harvard professor turns to private equity to counter Trump research cuts
Under the deal announced Monday, İş Private Equity, a Turkish firm, has committed $39 million to a laboratory run by Gökhan Hotamışlıgil, a professor of genetics and metabolism at the T.H. Chan School of Public Health. The firm, which is a branch of Turkey's İşbank Group, also plans to invest an undisclosed amount of money in any drug candidates that come out of Hotamışlıgil's laboratory and are moved into a new biotech called Enlila. It's a relatively modest deal, in the scope of investment banking. But the collaboration provides much-needed capital at a time when the model for funding scientific research has been thrown into chaos. Advertisement In the first six months of the Trump administration, government officials terminated at least Advertisement In all, Plans for the İş Private Equity collaboration pre-date the Trump administration's science grant retrenchment. Talks began last year, when Hotamışlıgil traveled to Turkey — where he was born and attended university — for a symposium celebrating İşbank Group's centennial. The event was filled with Nobel laureates, entrepreneurs, and others discussing the future of Turkey. Hotamışlıgil gave a presentation at the event detailing his experience as a scientist and his decades-long work exploring fatty acid binding proteins, or FABPs. This hormone is produced in fat cells and secreted into the blood, where it interacts with proteins to form a substance called fabkin. Elevated levels of fabkin are linked to obesity, The presentation caught the attention of İşbank's chief executive. Financing scientific research has always been a challenge, as Hotamışlıgil detailed to the İşbank Group event crowd. It's not easy to explore scientific unknowns while scrounging up grants and other capital. 'In the past, we were complaining about the principles of funding, which overwhelmingly tilted toward more conservative, more guaranteed outcomes… Then, suddenly, there was no funding,' Hotamışlıgil told STAT. Even now, Hotamışlıgil said he is shocked that a country like the U.S. would pull back its scientific financing so drastically, given how much success it's lent to large corporations and research institutions that elicit international envy. Advertisement The federal cuts have plunged many Chan School staff and faculty into cycles of grief and anger, said Amanda Spickard, the associate dean for research strategy and external affairs. They're now emerging from the daze to brainstorm new ways of replacing lost research dollars. In a letter sent out last week, the school's dean of faculty, Andrea Baccarelli, laid out an initial slate of strategies for replacing lost funding, including asking corporate partners to make $100,000 gifts to support Ph.D. students and post-doctorate fellows. The idea has been well-received by executives in need of highly trained employees, said Sarah Branstrator, managing director of academic strategy and research partnerships at the Chan School. School officials are also hopeful that the İşbank collaboration could be the first of multiple privately financed labs. There have been isolated examples in which investment firms have financed specific university centers or research projects, often for preferential access to any new scientific innovations that come out of the laboratories. Just across the Charles River from the Chan School, Harvard's Wyss Institute has spent the last five years working with an affiliate of the science-focused VC firm Northpond Ventures. Northpond initially committed $12 million to the alliance in 2020, and has made New York investment firm Deerfield Management has been much more aggressive in funding early-stage research. It has committed around $390 million to collaborations with Advertisement Hotamışlıgil's lab may be a unique case, as metabolism has become a hot area of drug development, thanks to the success of Eli Lilly and Novo Nordisk's GLP-1 weight loss medications. Obesity-focused startups are still raking in Meanwhile, other areas of public health research, like infectious diseases and vaccines, are a 'It is probably too optimistic to say that government funding could completely be replaced. Government funding is really crucial to keep science as its engine. Having said that, for the school faculty, there are incredible opportunities, in my view,' Hotamışlıgil said. '[This] gives some hope that there's also some alternative ways that we can support science.'
Yahoo
2 days ago
- Yahoo
Scatec's Obelisk solar project in Egypt attains financial close
Renewable energy solutions provider Scatec has reached financial close for its Obelisk hybrid solar and battery storage project in Egypt, which is to be delivered in two phases. Scatec will provide engineering, procurement and construction (EPC), asset management (AM), and operations and maintenance (O&M) services for the Obelisk project, with the EPC scope accounting for roughly 70% of the total capex. The non-recourse project financing includes $479.1m provided by the European Bank for Reconstruction and Development (EBRD), African Development Bank (AfDB), and British International Investment (BII). The amount covers approximately 80% of the total estimated capital expenditure of $590m. Scatec CEO Terje Pilskog said: 'Reaching financial close for this project marks a major milestone for Scatec. It proves our ability to deliver large-scale hybrid projects. "We are proud to partner with leading development finance institutions to support Egypt's clean energy ambitions, and we look forward to delivering this important project together with our partners.' The project's first phase comprises 561MW of solar power and 100MW/200MWh of battery storage. It is expected to reach commercial operational date (COD) in the first half of 2026. The second phase will add another 564MW of solar capacity in the latter half of the same year. Under a 25-year power purchase agreement (PPA) with the Egyptian Electricity Transmission Company (EETC), the generated energy will be sold in US dollars and is backed by a sovereign guarantee. Scatec previously secured equity bridge loans (EBL) totalling $120m for the project, which allows for the postponement of project equity injections until the end of the construction period. Furthermore, the company is in advanced talks with potential equity partners, with the expectation that these discussions will conclude in the coming months. "Scatec's Obelisk solar project in Egypt attains financial close" was originally created and published by World Construction Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
2 days ago
- Yahoo
Scatec signs PPA for 900MW wind project in Egypt
Scatec has entered a 25-year power purchase agreement (PPA) with the Egyptian Electricity Transmission Company (EETC) for the 900MW Shadwan wind power project. The agreement, signed through Scatec's dedicated project company Shadwan Wind Power, aims to strengthen Egypt's transition towards a sustainable renewable energy mix. The wind power project will be located in Ras Shukeir, recognised for some of the world's most favourable conditions for onshore wind power generation. Scatec CEO Terje Pilskog stated: 'This project is a testament to Scatec's position as one of the leading renewables companies in Egypt. 'We are now advancing four major renewables projects in the country, with a diversified technology base. I would like to thank all parties involved for making this happen, with a particular acknowledgement to the skills and persistence of our Egyptian team.' Comprehensive wind measurements will shortly be conducted at the site. These measurements are scheduled to conclude in the first quarter of 2026. In a related development, Scatec has announced the closure of a non-recourse project financing of $479.1m for the 1.1GW Obelisk solar and battery storage project being developed in the Nagaa Hammadi region of Egypt. The financing is being provided by the European Bank for Reconstruction and Development (EBRD), the African Development Bank (AfDB) and British International Investment (BII). The financing amount represents 80% of the total estimated capital expenditure of $590m. The Obelisk solar project will be developed in two phases, with the first phase comprising 561MW of solar power and 100MW/200 megawatt hours (MWh) of battery storage. It is expected to achieve its commercial operational date in the first half of 2026. The second phase, which will add 564MW of solar capacity, is scheduled for completion in the latter half of 2026. The generated energy from the project will be sold under a 25-year PPA with the EETC. Scatec has previously secured equity bridge loans amounting to $120m for the project. Pilskog stated: 'Reaching financial close for this project marks a major milestone for Scatec. It proves our ability to deliver large-scale hybrid projects. 'We are proud to partner with leading development finance institutions to support Egypt's clean energy ambitions, and we look forward to delivering this important project together with our partners.' In early June 2025, Scatec was awarded preferred bidder status for the 123MW/492MWh Haru battery energy storage system project in South Africa. "Scatec signs PPA for 900MW wind project in Egypt" was originally created and published by Power Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data